Form 4 for OCUL OCULAR THERAPEUTIX, INC
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-11 · accession 0001104659-25-013153 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-13 | 2025-02-11 | OCUL | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +111.0K | 285.4K | +64% | $0 |
| D | 2025-02-13 | 2025-02-11 | OCUL | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +334.0K | 334.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-11 | A | A | 111,000 | $0.00 | 285,380 | D | — | — | (F1) On February 11, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-02-11 | A | A | 334,000 | $0.00 | 334,000 | D | $7.44 · — to 2035-02-10 | 334,000 Common Stock | (F2) Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. |